Outcomes of random-start letrozole protocol with PGT-A in women with breast cancer undergoing fertility preservation
dc.authorscopusid | 31767766600 | en_US |
dc.authorwosid | CDM-6595-2022 | en_US |
dc.contributor.author | Turan, Volkan | |
dc.contributor.author | Gayete-Lafuente, Sonia | |
dc.contributor.author | Bang, Heejung | |
dc.contributor.author | Oktay, Kutluk H. | |
dc.date.accessioned | 2023-07-27T08:32:53Z | |
dc.date.available | 2023-07-27T08:32:53Z | |
dc.date.issued | 2023 | en_US |
dc.department | Fakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Kadın Hastalıkları ve Doğum Ana Bilim Dalı | en_US |
dc.description.abstract | PURPOSE : To compare the cycle characteristics and outcomes of random-start-controlled ovarian stimulation (RSCOS) protocols to the outcomes of standard-start-controlled ovarian stimulation (SSCOS) cycles and to report the utility of PGT-A in these cycles. Methods: One hundred and seventeen who underwent SSCOS and 39 who underwent RSCOS for oocyte and/or embryo cryopreservation before breast cancer chemotherapy were retrospectively evaluated. Mean number of embryos and blastocyst euploidy rates were the main outcome measures. Results: A majority of RSCOS cycles were initiated in the luteal phase (66.6% luteal vs. 33.3% follicular). While the total dose of gonadotropins was significantly higher in the RSCOS (3720.8 ± 1230.0 vs. 2345.1 ± 803.6 IU; P < 0.001), the mean number of mature oocytes and embryos was similar to SSCOS. However, there was a trend for a higher number of mean embryos with luteal start RSCOS (6.9 ± 2.7 in late follicular start vs. 9.4 ± 4.2 in luteal start, P = 0.08). PGT-A was performed in 48% of the cases that underwent embryo cryopreservation in RSCOS (12 women, mean age = 35.3 ± 4.1; 87 blastocysts), revealing a euploidy rate of 36.2 ± 22.3% per patient. This rate was comparable to a 45% aneuploidy rate from similarly aged published data. Of the 7 RSCOS patients who returned for frozen embryo transfer, 5 delivered and one has an ongoing pregnancy, while in SSCOS, 18 out of 40 cycles resulted in live birth. Conclusion: Our data suggests that RSCOS fertility preservation cycle outcomes are similar to those with SSCOS and result in age-appropriate euploidy rates. | en_US |
dc.description.sponsorship | United States Department of Health & Human Services National Institutes of Health (NIH) - USA NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) RO1 HD053112 | en_US |
dc.identifier.citation | Turan, V., Gayete-Lafuente, S., Bang, H., & Oktay, K. H. (2023). Outcomes of random-start letrozole protocol with PGT-A in women with breast cancer undergoing fertility preservation. Journal of Assisted Reproduction and Genetics, 40(10), pp. 2401-2408 https://doi.org/10.1007/s10815-023-02882-0 | en_US |
dc.identifier.doi | 10.1007/s10815-023-02882-0 | en_US |
dc.identifier.endpage | 2408 | en_US |
dc.identifier.issn | 1573-7330 | |
dc.identifier.issn | 1058-0468 | |
dc.identifier.issue | 10 | en_US |
dc.identifier.pmid | PMID: 37488389 | en_US |
dc.identifier.scopus | 2-s2.0-85165427132 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 2401 | en_US |
dc.identifier.uri | https://doi.org/10.1007/s10815-023-02882-0 | |
dc.identifier.uri | https://hdl.handle.net/20.500.13055/508 | |
dc.identifier.volume | 40 | en_US |
dc.identifier.wos | WOS:001034502400001 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.indekslendigikaynak.other | SCI-E - Science Citation Index Expanded | en_US |
dc.institutionauthor | Turan, Volkan | |
dc.language.iso | en | en_US |
dc.publisher | Springer/Plenum Press | en_US |
dc.relation.ispartof | Journal of Assisted Reproduction and Genetics | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Breast Cancer | en_US |
dc.subject | Embryo | en_US |
dc.subject | Letrozole | en_US |
dc.subject | Preimplantation Genetic Testing | en_US |
dc.subject | Random-Start-Controlled Ovarian Stimulation | en_US |
dc.title | Outcomes of random-start letrozole protocol with PGT-A in women with breast cancer undergoing fertility preservation | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication |
Dosyalar
Orijinal paket
1 - 1 / 1
Kapalı Erişim
- İsim:
- Outcomes of random-start letrozole protocol with PGT-A in women with breast cancer undergoing fertility preservationn.pdf
- Boyut:
- 557.37 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text
Lisans paketi
1 - 1 / 1
Kapalı Erişim
- İsim:
- license.txt
- Boyut:
- 1.44 KB
- Biçim:
- Item-specific license agreed upon to submission
- Açıklama: